Conference Coverage

Two behavioral therapies are on par for alleviating insomnia in cancer survivors

Publish date: June 5, 2014

 

AT SLEEP 2014

Dr. Garland disclosed no relevant conflicts of interest.

Pages

Recommended Reading

FDA requiring lower starting dose for another sleep drug, eszopiclone
MDedge Internal Medicine
Home-based OSA testing beats lab-based testing on cost
MDedge Internal Medicine
A CPAP alternative, implantable tongue stimulator is ahead for apnea
MDedge Internal Medicine
CPAP adherence improves with partner support
MDedge Internal Medicine
Suicide more likely after midnight
MDedge Internal Medicine
Ozone increased apnea, bradycardia in healthy sleeping infants
MDedge Internal Medicine
People with SAD have reduced retinal sensitivity to light year round
MDedge Internal Medicine
Sleep society: Screen for apnea at first Medicare visit
MDedge Internal Medicine
Novel agent counters sleepiness in narcolepsy patients
MDedge Internal Medicine
CBT-I delivered by health educators eased insomnia in older adults
MDedge Internal Medicine